Skip to main content

Table 3 Expression of TLRs in/on leukocytes in SRMA (percentage of positive cells, median and 25% to 75% range)

From: Toll-like receptors 4 and 9 are responsible for the maintenance of the inflammatory reaction in canine steroid-responsive meningitis-arteritis, a large animal model for neutrophilic meningitis

TLRs

SRMA A

significant differences (P <0.05)

tendencies

CSF PMNs

TLR3

2.4 (1.5 to 3.7)

none

Neopl↑

TLR9

94.1 (53.8 to 99.0)

none

 

TLR2

83.8 (79.6 to 90.9)

none

 

TLR4

93.1 (81.7 to 95.3)

MUE↓

 

Neopl↓

TLR5

91.6 (70.9 to 95.3)

MUE↓

 

Neopl↓

CSF monocytes

 

TLR3

14.4 (3.7 to 30.5)

none

 

TLR9

85.0 (48.0 to 95.0)

none

MUE↓

TLR2

87.0 (78.9 to 94.3)

none

MUE↓

TLR4

82.6 (74.5 to 93.2)

none

 

TLR5

83.3 (62.8 to 94.1)

none

 

CSF lymphocytes

 

TLR3

2.9 (1.0 to 11.6)

none

SRMA Th↑

TLR9

2.9 (18.8 to 1.5)

none

mix↓

TLR2

13.0 (8.1 to 18.0)

BM↓

 

MUE↓

TLR4

13.0 (3.0 to 23.9)

SRMA Th↑

 

BM↓

Mix↑

TLR5

11.1 (3.7 to 18.8)

none

BM↓

PB PMNs

 

TLR3

7.5 (5.3 to 11)

Pyo↓

Neopl↑

Healthy↑

TLR9

96.3 (60.8 to 97.7)

Healthy↓

Mix↓

TLR2

98.7 (98.1 to 99.3)

Healthy↓

SRMA Th↓

Mix↓

TLR4

98.6 (98.1 to 99.7)

Healthy↓

 

Mix↓

TLR5

99.0 (97.4 to 99.5)

Healthy↓

 

PB monocytes

 

TLR3

8.6 (4.5. to 15.21)

Pyo↓

Neopl↑

Healthy↓

TLR9

92.1 (67.2 to 96.9)

SRMA Th↓

Pyo↓

Healthy↓

TLR2

96.3 (94.0 to 97.9)

SRMA Th↓

 

Neopl↓

Mix↓

TLR4

95.6 (93.3 to 96.9)

SRMA Th↓

Neopl↓

Mix↓

Healthy↓

TLR5

95.3 (92.3 to 97.4)

Healthy↓

Mix↓

PB lymphocytes

 

TLR3

4.0 (3.1 to 5.8)

none

 

TLR9

85.2 (71.2 to 92.8)

none

Pyo↓

Healthy↓

TLR2

6.4 (4.5 to 13.6)

BM↓

MUE↑

Healthy↑

Neopl↑

TLR4

8.2 (3.8 to 13.5)

BM↓

Pyo↑

Healthy↑

TLR5

6.125 (4.4 to 18.7)

none

BM↓

Healthy↑

  1. BM, bacterial meningitis; Healthy, healthy dogs; Mix, miscellaneous diseases of the nervous system; MUE, meningoencephalitis of unknown etiology; PMNs, polymorphonuclear cells; Pyo, pyogenic infection; SRMA, steroid-responsive meningitis-arteritis; SRMA A, SRMA acute; SRMA Th, SRMA under therapy; TLR, Toll-like receptor.
  2. (↓) lower or (↑) higher values in comparison to SRMA A.